Defunct Company
Total Trials
10
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,324
NCT00494949
Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 30, 2003
Completion: Aug 31, 2006
NCT00425334
Safety Study of Hemospan® in Prostatectomy Patients
Phase: Phase 2
Start: Jul 31, 2005
Completion: Nov 30, 2007
NCT00420277
Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty
Phase: Phase 3
Start: Feb 28, 2007
Completion: Apr 30, 2008
NCT00421200
Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty
Completion: Jun 30, 2008
NCT00633659
Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia
Start: Sep 30, 2007
Completion: Dec 31, 2008
NCT01004198
Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Start: Dec 31, 2009
Completion: Jun 30, 2010
NCT01262196
Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Start: May 31, 2011
Completion: Nov 30, 2012
NCT01356485
Safety Study of MP4CO in Adult Sickle Cell Patients
Phase: Phase 1
Start: Jan 31, 2012
Completion: Dec 31, 2012
NCT01925001
Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
Start: Oct 31, 2013
Completion: Oct 31, 2015
NCT01973504
Phase 2c Dose Comparison Study of MP4OX in Trauma
Start: Dec 31, 2013
Completion: Mar 31, 2016